Time-dependent CYP3A Inhibition (HLM; midazolam substrate) - US
OVERVIEW
DOCUMENTS/REFERENCES
Biological Information
Background Information:
Cytochrome P450 (CYP) inhibition is one of the most common types of drug-drug interactions (DDI) and can be exhibited in either a reversible or time-dependent manner. This assay is designed to determine if a test compound is an irreversible, time-dependent inhibitor of CYP3A4 in human liver microsomes
No. of Assays on Panel:
2
Assays on Panel:
Family
CYP450
Name
Time-dependent CYP3A inhibition (HLM, midazolam substrate + NADPH) - US
Item
2184
Protein
CYP3A4
Organism
Human
Assay Sub Type
Enzymatic
Family
CYP450
Name
Time-dependent CYP3A inhibition (HLM, midazolam substrate - NADPH) - US
Item
2185
Protein
CYP3A4
Organism
Human
Assay Sub Type
Enzymatic
Family:
CYP450
Sub Family:
CYP3
Protein Name:
CYP3A4
Uniprot Number:
P08684
Gene Name:
CYP3A4
Gene ID:
1576
Organism:
Human
Construct Details:
Microsomes
Tissue:
Liver
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Testing Information
Substrate:
midazolam
Test Concentration / Dose:
Assay is performed with each concentration tested using 2 replicate(s)
Test Sample Requirements:
Minimum for 1) Screen: 100 μl of 10 mM stock -OR- 1 to 2 mg (pre-weighed). 2) Dose Response: 250 μl of 10 mM stock -OR- 1.5 to 2 mg (pre-weighed).
Turnaround Time
Standard:
10 Business Days
Additional Information
Brand:
Cerep
Testing Location:
USA - St Charles, MO
RELATED SOLUTIONS
CYP3A4 inhibition (recombinant, BFC substrate) - US
Item: 391
CYP3A4 inhibition (recombinant, BzRes substrate) - US
Item: 939
CYP3A4 inhibition (recombinant, testosterone substrate) - US
Item: 940
CYP3A4 inhibition (recombinant, midazolam substrate) - US
Item: 1183
Intrinsic clearance (CYP3A4) - US
Item: 1649
CYP3A inhibition (HLM, testosterone substrate) - US
Item: 1769
CYP3A inhibition (HLM, midazolam substrate) - US
Item: 1770
Time-dependent CYP3A inhibition (HLM, midazolam substrate + NADPH) - US
Item: 2184
Time-dependent CYP3A inhibition (HLM, midazolam substrate - NADPH) - US
Item: 2185
CYP3A4 induction (human hepatocytes, mRNA level, 1 donor) - US
Item: 3864
CYP3A4 induction (human hepatocytes, mRNA level, 3 donors) - US
Item: 3865
Questions? Contact Us
You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.
